tiprankstipranks
Imagion Biosystems Ltd. (AU:IBX)
ASX:IBX
Australian Market

Imagion Biosystems Ltd. (IBX) Price & Analysis

Compare
8 Followers

IBX Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

3.07%96.93%
Mutual Funds
― Other Institutional Investors
96.93% Public Companies and
Individual Investors

IBX FAQ

What was Imagion Biosystems Ltd.’s price range in the past 12 months?
Imagion Biosystems Ltd. lowest share price was AU$0.01 and its highest was AU$0.10 in the past 12 months.
    What is Imagion Biosystems Ltd.’s market cap?
    Imagion Biosystems Ltd.’s market cap is AU$3.22M.
      When is Imagion Biosystems Ltd.’s upcoming earnings report date?
      Imagion Biosystems Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 149 days.
        How were Imagion Biosystems Ltd.’s earnings last quarter?
        Imagion Biosystems Ltd. released its earnings results on Feb 28, 2025. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
          Is Imagion Biosystems Ltd. overvalued?
          According to Wall Street analysts Imagion Biosystems Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Imagion Biosystems Ltd. pay dividends?
            Imagion Biosystems Ltd. does not currently pay dividends.
            What is Imagion Biosystems Ltd.’s EPS estimate?
            Imagion Biosystems Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Imagion Biosystems Ltd. have?
            Imagion Biosystems Ltd. has 201,341,420 shares outstanding.
              What happened to Imagion Biosystems Ltd.’s price movement after its last earnings report?
              Imagion Biosystems Ltd. reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Imagion Biosystems Ltd.?
                Currently, no hedge funds are holding shares in AU:IBX
                ---

                Company Description

                Imagion Biosystems Ltd.

                Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Biotron Limited
                Mesoblast Limited
                PYC Therapeutics Limited
                Resonance Health Ltd
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis